Development of semisolid pharmaceutical forms with mometasone furoate
DOI:
https://doi.org/10.2478/amma-2023-0045Keywords:
mometasone furoate, hydrogel, diffusion, dermal administrationAbstract
Objective This study aims to develop semisolid pharmaceutical forms for the topical administration of mometasone furoate.
Methods Two creams (O1 and O2) and four hydroxypropyl methylcellulose-based hydrogels were prepared (H3-H6). Two different sorts of hydroxypropyl methylcellulose were used in concentrations of 15 and 20%. Consistency, spreadability, viscosity, and pH were measured. In vitro drug release was determined by a vertical diffusion cell. Mathematical models were applied for a better understanding of release phenomena.
Results O1 and O2 presented lower values for penetration depth and spreadability. Hydrogel viscosity is influenced by the type and concentration of the gel-forming agent. Viscosity decreases in the order H6, H5, H4, and H3. pH varies between 4.6 to 5.92, fulfilling the requirements of European Pharmacopiea. Creams showed 5.49 and 6.59% of mometasone released after 6 hours. The lowest viscosity hydrogel presented the best dissolution of 40.11% mometasone after 6 hours.
Conclusions H3 hydrogel releases the highest amount of mometasone furoate after 6 hours. The release is best described by the Korsmeyer-Peppas model explained by water diffusion and polymeric chain relaxation happen during the swelling of the polymer.
Downloads
Published
How to Cite
Issue
Section
License
Acta Marisiensis Seria Medica provides immediate open access to its content under the Creative Commons BY 4.0 license.






